| 01/02 | Spero Therapeutics, Inc. : Change in Directors or Principal Officers (form 8-K) |  |
| 01/02 | Spero Therapeutics, Inc. Appoints Timothy Keutzer as Chief Operating Officer, Effective.. | |
| 31/01 | Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| 09/01 | Spero Therapeutics, Inc. : Results of Operations and Financial Condition, Regulation FD Di.. | |
| 2022 | Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from N.. | |
| 2022 | Spero Therapeutics to Present at the 5th Annual Evercore ISI HealthCONx Conference | |
| 2022 | Earnings Flash (SPRO) SPERO THERAPEUTICS Posts Q3 Revenue $2M | |
| 2022 | SPERO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a.. | |
| 2022 | Spero Therapeutics Announces Third Quarter 2022 Operating Results and Provides Business.. | |
| 2022 | Spero Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months.. | |
| 2022 | Spero Therapeutics Closes License Deal With GSK for Investigational Drug for Urinary Tr.. | |
| 2022 | Spero Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-K) | |
| 2022 | Spero Therapeutics Announces Closing of Exclusive License Agreement with GSK for Tebipe.. | |
| 2022 | Spero Therapeutics Announces Closing of Exclusive License Agreement with GSK for Tebipe.. | |
| 2022 | Spero Therapeutics, Inc. announced that it has received $8.999973 million in funding fr.. | |
| 2022 | Spero Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial R.. | |
| 2022 | Spero Therapeutics to Present Data at IDWeek 2022 | |
| 2022 | Spero Therapeutics to Present Data at IDWeek 2022 | |
| 2022 | Spero Therapeutics to Host Virtual R&D Event on Non-Tuberculous Mycobacterial Pulmonary.. | |
| 2022 | North American Morning Briefing: Stock Futures -2- | |
| 2022 | GSK and Spero Therapeutics announce exclusive licence agreement for tebipenem HBr, a la.. | |
| 2022 | USA-Les valeurs à suivre à Wall Street (actualisé) |  |
| 2022 | ADRs End Mostly Lower; Compagnie de Saint-Gobain Trades Actively | |
| 2022 | Sector Update: Health Care Stocks Gain Thursday Afternoon | |
| 2022 | Sector Update: Health Care | |
| 2022 | Top Midday Gainers | |
| 2022 | Global markets live: Veolia, Meta, Amazon, Salesforce, Target... | |
| 2022 | Fed up! | |
| 2022 | Sector Update: Health Care Stocks Mixed Premarket Thursday | |
| 2022 | Sector Update: Health Care | |
| 2022 | BOE Raises rates Again, Cuts Inflation Expectations | |
| 2022 | Spero Therapeutics Shares Take Flight Premarket on GSK Pact | |
| 2022 | Pound Rises Before Likely BOE Rate Rise But Seen Vulnerable | |
| 2022 | FTSE 100 Drops Ahead of BOE; Weak Earnings Hit JD Sports | |
| 2022 | Spero Therapeutics, Inc. : Entry into a Material Definitive Agreement, Unregistered Sale o.. | |
| 2022 | GSK : accord de licence avec Spero Therapeutics | |
| 2022 | US Stock Futures Trend Lower Following Fed Rate Increase of 75 Basis Points | |
| 2022 | Top Premarket Gainers | |
| 2022 | GSK plc and Spero Therapeutics, Inc. Announce Exclusive Licence Agreement for Tebipenem.. | |
| 2022 | UK Poorly Positioned to Cope With Rising Interest Rates | |
| 2022 | GSK Receives Exclusive License for Spero Therapeutics' Oral Antibiotic Candidate | |
| 2022 | GSK eyes Spero's experimental urinary tract infection drug, takes stake | |
| 2022 | FTSE 100 to Tumble After Heavy U.S. Losses, Fed Hike | |
| 2022 | GSK takes stake in Spero in deal for experimental UTI treatment | |
| 2022 | GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiot.. | |
| 2022 | GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiot.. | |
| 2022 | GSK Secures Urinary Tract Infections Treatment License With Spero Therapeutics | |
| 2022 | Spero Therapeutics, Inc. announced that it expects to receive $8.999973 million in fund.. | |
| 2022 | Spero Therapeutics, Inc. : Change in Directors or Principal Officers, Submission of Matter.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from S.. | |
| 2022 | Spero Therapeutics Announces Appointment of Kamal Hamed, MD, MPH, MBA, as Chief Medical.. | |
| 2022 | Spero Therapeutics Announces Appointment of Kamal Hamed as Chief Medical Officer | |
| 2022 | Spero Therapeutics to Present at Upcoming Investor Conference | |
| 2022 | Spero Therapeutics Shares Up 38% On FDA's Feedback of Tebipenem HBr Program | |
| 2022 | Spero Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-K) | |
| 2022 | Spero Therapeutics Provides Tebipenem HBr Program Update Following Type A Meeting with .. | |
| 2022 | Spero Therapeutics Provides Tebipenem HBr Program Update Following Type A Meeting with .. | |
| 2022 | Spero Therapeutics : Announces Second Quarter 2022 Operating Results and Provides Business.. | |
| 2022 | Earnings Flash (SPRO) SPERO THERAPEUTICS Posts Q2 Revenue $2M | |
| 2022 | SPERO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a.. | |
| 2022 | Spero Therapeutics Announces Second Quarter 2022 Operating Results and Provides Busines.. | |
| 2022 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months.. | |
| 2022 | Spero Therapeutics to Provide Business Update and Report Second Quarter 2022 Financial .. | |
| 2022 | Spero Therapeutics, Inc. : Change in Directors or Principal Officers (form 8-K) | |
| 2022 | Spero Therapeutics : Receives Complete Response Letter from U.S. Food and Drug Administrat.. | |
| 2022 | Spero Therapeutics Sinks After-Hours as FDA Rejects Tebipenem HBr New Drug Application | |
| 2022 | Spero Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-K) | |
| 2022 | Spero Therapeutics, Inc. Receives Complete Response Letter from the U.S. Food and Drug .. | |
| 2022 | Spero Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administra.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from R.. | |
| 2022 | Spero Therapeutics, Inc. : Termination of a Material Definitive Agreement, Financial State.. | |
| 2022 | Earnings Flash (SPRO) SPERO THERAPEUTICS Posts Q1 Revenue $2.1M, vs. Street Est of $1.9.. | |
| 2022 | SPERO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a.. | |
| 2022 | Spero Therapeutics Announces First Quarter 2022 Operating Results and Provides Business.. | |
| 2022 | Spero Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31,.. | |
| 2022 | Spero Therapeutics to Present at Upcoming Investor Conferences | |
| 2022 | Spero Therapeutics to Provide Business Update and Report First Quarter 2022 Financial R.. | |
| 2022 | Top Midday Decliners | |
| 2022 | Spero Therapeutics Shares Drop 66%, Hit 52-Week Low | |
| 2022 | Spero Therapeutics Cuts 75% Workforce, Ends Urinary Tract Infection Drug; Shares Sink | |
| 2022 | Wall Street Set for Small Gains Ahead of Fed Meeting | |
| 2022 | Top Premarket Decliners | |
| 2022 | Spero Therapeutics, Inc. : Costs Associated with Exit or Disposal Activities, Change in Di.. | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Rapport
